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aternal embryonic leucine zipper kinase (MELK)
was previously identified in a screen for genes
enriched in neural progenitors. Here, we dem-
onstrate expression of MELK by progenitors in developing
and adult brain and that MELK serves as a marker for self-
renewing multipotent neural progenitors (MNPs) in cultures
derived from the developing forebrain and in transgenic
mice. Overexpression of MELK enhances (whereas knock-
down diminishes) the ability to generate neurospheres
from MNPs, indicating a function in self-renewal. MELK
M
 
down-regulation disrupts the production of neurogenic
MNP from glial fibrillary acidic protein (GFAP)–positive
progenitors in vitro. MELK expression in MNP is cell cycle
regulated and inhibition of MELK expression down-regu-
lates the expression of B-myb, which is shown to also me-
diate MNP proliferation. These findings indicate that MELK
is necessary for proliferation of embryonic and postnatal
MNP and suggest that it regulates the transition from
GFAP-expressing progenitors to rapid amplifying progeni-
tors in the postnatal brain.
 
Introduction
 
Neural stem cells are defined by their ability to self-renew, and
their capacity to produce neurons, astrocytes, and oligodendro-
cytes (Gage, 2000; Momma et al., 2000; Panchision and McKay,
2002). In the adult subventricular zone (SVZ), slowly prolifera-
tive glial fibrillary acidic protein (GFAP)–positive cells are
thought to be neural stem cells that give rise to a more rapidly
proliferative, GFAP-negative progenitor (for review see Alva-
rez-Buylla et al., 2002). In early brain development it is not clear
whether such distinctions exist, although there are large numbers
of highly proliferative multipotent neural progenitors (MNP) in
the periventricular neuroepithelium. MNP proliferation plays
important roles in brain development, regulating cell number and
brain size (Groszer et al., 2001; Molofsky et al., 2003).
Previously, we used a genome-wide screening strategy to
discover genes that regulate MNP function (Geschwind et al.,
2001; Easterday et al., 2003). We reasoned that at least some of
the genes expressed by MNP and not by differentiated cells
would be those involved in self-renewing proliferation. We
used a combination of cDNA subtraction and microarray anal-
yses to discover genes expressed in different kinds of MNP-
containing neurospheres, as well as by other self-renewing
populations; hematopoietic stem cells and embryonic stem
(ES) cells. We then used in situ hybridization analysis to nar-
row this pool of genes by determining which ones were highly
expressed in developing germinal zones (GZs), providing in
vivo relevance to the in vitro studies (Geschwind et al., 2001;
Terskikh et al., 2001; Easterday et al., 2003).
Maternal embryonic leucine zipper kinase (MELK;
MPK38) (Gil et al., 1997; Heyer et al., 1997, 1999), a member
of the snf1/AMPK family of serine–threonine kinases, was en-
riched in multiple MNP-containing populations and in hemato-
poietic stem cells (Easterday et al., 2003). Although several
members of the family are known to play roles in cell survival
under metabolically challenging conditions, the function of
MELK has not previously been determined (Kato et al., 2002;
Inoki et al., 2003; Suzuki et al., 2003a,b).
Here, we show that MELK is expressed by MNP derived
from several ages, and is necessary for their proliferation in
vitro, influencing their ability to form neurospheres, a measure
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of self-renewal. The data strongly support the hypothesis that
MELK, unlike other family members, functions by regulating
the cell cycle, rather than cell survival by itself, possibly
through the regulation of the B-myb proto-oncogene. MELK is
also required for the transition of GFAP-positive progenitor
cells to highly proliferative GFAP-negative cells in vitro.
These data validate our general approach and demonstrate an
important role for MELK in neural progenitor biology.
 
Results
 
MELK is expressed by neural progenitors
 
Because MNP characteristics depend upon the age at which
they are isolated, producing neurons earlier and glia at later
developmental times (Qian et al., 2000; Irvin et al., 2003), we
analyzed MELK expression in neurospheres derived from dif-
ferent aged animals. MELK was expressed by NS from embry-
onic day 12 (E12) telencephalon, as well as E17 and P0 cortex
(Fig. 1 A, a). After growth factor withdrawal, MELK mRNA
levels declined dramatically, to 
 

 
10% of the original expres-
sion after 24 h (Fig. 1 A, b). MELK was also expressed in NS
derived from adult striatal SVZ (unpublished data).
MELK expression declined as progenitor differentiation
proceeded, whether the differentiation was induced by growth
factor withdrawal or addition of retinoic acid (Fig. 1 B). NS
differentiation was confirmed by increased expression of neu-
rofilament heavy chain (NFH), GFAP, and proteolipid protein
(PLP)—markers for neuronal, astrocytic, and oligodendroglial
differentiation, respectively.
 
MELK mRNA expression in GZs in vivo
 
RT-PCR analysis shows that MELK mRNA was expressed in
the developing brain during early and mid-embryonic periods
with a dramatic decline between E15 and E17, with no detectable
expression in adult whole brain or lung (used as a control tissue)
(Fig. 2 A). MELK expression in ES cells was relatively high.
In situ hybridization (Fig. 2 B) demonstrated that MELK
mRNA was expressed throughout the central nervous system
(CNS) within periventricular GZs as early as E9. This general
pattern of expression persisted through early postnatal periods
to adulthood, including cells of the anterior subventricular zone
(SVZa) and rostral migratory stream (Fig. 2 B, b–h). No spe-
cific hybridization was detectable in the CNS outside of GZs,
indicating that MELK is not expressed by mature cell types. In
the adult brain, the only hybridization found was in the SVZ
lining the lateral ventricle (Fig. 2 B, h) along its entire rostro-
caudal extent, but within only a minority of SVZ cells along the
lateral side of the lateral ventricle (Fig. 2 D, arrows). No label-
ing was detected in adult hippocampus (HC) (Fig. 2 D, a and b)
or other GZs. Lack of detection of MELK in hippocampus was
further confirmed by RT-PCR (Fig. 2 C).
To further define cell types that express MELK, we per-
formed double labeling with in situ hybridization and immu-
nohistochemistry (Fig. 3). In the brain, MELK was expressed
by proliferating cell nuclear antigen (PCNA)–positive cells
(Fig. 3 A, a–e). Outside the brain (in the same sections) we
did not detect MELK mRNA in PCNA-positive cells, indicat-
ing that MELK is not universally expressed by dividing cells
(Fig. 3 A, f).
MELK was also expressed by GFAP-containing cells, al-
though the extent of this colocalization was dependent on the de-
velopmental stage. Throughout embryonic and early postnatal
ages, MELK-expressing cells were GFAP-negative (Fig. 3 B, a
and b, insets) because there is little or no SVZ GFAP expression
at these ages (Imura et al., 2003; Fox et al., 2004). Subsequently,
as GFAP expression increased in the SVZ, MELK mRNA was
detected in some SVZ GFAP-expressing cells. In the adult SVZ,
MELK expression was also detectable in GFAP-positive cells
(Fig. 3 B, inset in c). MELK, unlike the adult case, was expressed
in the hippocampus during early postnatal ages, at least up to P7,
within GFAP-positive cells at the hilar border of the dentate gy-
Figure 1. MELK is highly enriched in cultures containing multipotent pro-
genitors. (A, a) MELK expression as determined by semiquantitative RT-PCR
using GAPDH as a standard in neurospheres (NS) and differentiated sister
cultures generated by the withdrawal of bFGF (DC) derived from telen-
cephalon (E12) or cerebral cortex (E17, P0). (b) Quantitative RT-PCR of
MELK expression during differentiation of neurospheres derived from E11
telencephalon. (B) RT-PCR analysis of MELK, and lineage-specific markers
during E12 neurosphere (NS) differentiation induced by mitogen with-
drawal or stimulation of retinoic acid and FBS at the times indicated.
Abbreviations: NFH, neurofilament heavy chain; GFAP, glial fibrillary
acidic protein; PLP, proteolipid protein.
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rus (Fig. 3 C, inset in a). TuJ1-positive neurons in the dentate gy-
rus or anywhere else did not express MELK (Fig. 3 C, inset in b).
MELK mRNA was also identified within the external
granule cell layer (EGL) of the developing cerebellum (Fig. 3
D) within the outer proliferative EGL with no expression in the
inner, premigratory, TuJ1-positive zone (Fig. 3 D, c). Expres-
sion in the EGL was detectable as early as the EGL could be
distinguished clearly at E13 (unpublished data), and disap-
peared along with the EGL during later postnatal development.
 
The MELK promoter lies upstream of its 
first exon, and is active only in 
undifferentiated neural progenitors
 
The isolation and initial characterization of a 3.5-kb mouse and
human MELK promoter (PMELK) is described in the online
supplemental data (available at http://www.jcb.org/cgi/content/
full/jcb.200412115/DC1). To investigate the specificity of the
PMELK sequence, cells were transfected with PMELK-EGFP
or control vectors and then sorted based on EGFP expression.
RT-PCR analysis was used to detect MELK expression both
in EGFP-positive and -negative populations (Fig. 4 A). The
PMELK-EGFP–positive fraction was highly enriched for
MELK mRNA as compared with the EGFP-negative fraction
or unsorted cells (Fig. 4 A, c).
Using the PMELK-EGFP construct, we characterized the
cellular specificity of MELK expression in cortical progenitors
derived from E12 embryos (Fig. 4 B). Cells expressing EGFP
driven by the CMV promoter were morphologically heteroge-
neous, whereas MELK promoter-driven EGFP-positive cells
were relatively homogeneous with a fusiform shape (Fig. 4 B).
MELK-positive cells expressed the neural progenitor markers
nestin, NG2, RC2, BLBP, and SOX2 in proliferating cultures
(Fig. 4 B, a–o), but no PMELK-driven EGFP was detected
in cells expressing differentiation markers (TuJ1, neurons,
Figure 2. Developmental and regional expression of
MELK mRNA in vivo. (A, a) MELK expression in ES cells
and during brain development analyzed by RT-PCR. The
triangle indicates increasing cycle number. (B) In situ hy-
bridization with radiolabeled antisense MELK cRNA.
Arrows in indicate the neuroepithelium. Arrowhead in h
points to the cerebellum. (e) Sense probe. (C) RT-PCR
analysis of different regions of adult brain. (D) Emulsion-
dipped brain section (counterstained by GFAP immuno-
histochemistry) demonstrating hybridization in scattered
cells within the forebrain SVZ (a, arrows), but absence of
MELK hybridization in the hippocampus (b). Abbreviations:
CX, cerebral cortex; HC, hippocampus; OB, olfactory
bulb; BS, brain stem; CB, cerebellum. Bar in B: 13.7 mm
in a; 8.9 mm in b; 5.5 mm in d–f; 4.1 mm in g; 7.8 mm in
h; and 4.5 mm in i. Bar in D: 750 m in top; 75 m in
a; 75 m in b.
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GFAP, astrocytes and O4, oligodendrocytes), even in prolifer-
ating cultures (Fig. 4 B, p–v). These data indicate that the
MELK promoter is active only in neural progenitors, and not
in more differentiated cells. Furthermore, the data are consis-
tent with, and support the findings of, native MELK expres-
sion described above.
 
MELK is a marker for tripotent, self-
renewing progenitors in embryonic 
cortical cultures
 
MNPs have the fundamental properties of self-renewal and mul-
tipotency. Therefore, we tested the ability of MELK-expressing
cells to form primary and secondary neurospheres and examined
the differentiation capacity of these spheres. The LeX antigen is
expressed by neural progenitors, and LeX-positive cells form
neurospheres (Capela and Temple, 2002). Immunocytochemis-
try shows that virtually all EGFP-expressing cells also ex-
pressed LeX (Fig. 5 A). Cultures from E12 telencephalon were
then separated by FACS using an anti-LeX antibody (Fig. 5 B).
Approximately 65% of the cells in the cultures were LeX-posi-
tive (Fig. 5 B, a and b). RT-PCR analysis demonstrated that
MELK mRNA was completely restricted to the LeX-positive
fraction (Fig. 5 B, c). LeX sorting also resulted in enrichment of
other neural stem cell–associated genes, including nucleostemin
(NCS) and SOX2. In contrast, musashi1 (Msi1) and GFAP were
not enriched in the LeX-positive fraction (Fig. 5 B, c), consis-
tent with previous observations of their expression in both pro-
genitor and nonprogenitor populations (Kaneko et al., 2000).
We next tested the capacity of MELK-expressing cells to
form neurospheres. MELK-positive E15 progenitors generated
 

 
5 times more primary neurospheres than LeX-positive cells
at a density (2,000 cells/ml) where most spheres form from a
single cell (Tropepe et al., 1999) (Fig. 5 C). Given that virtually
all MELK-positive cells express LeX, these data suggest that
the MELK-positive fraction of LeX-expressing cells is more
highly enriched for sphere-initiating cells. LeX-negative popu-
lations did not generate neurospheres under these conditions.
Primary spheres derived from MELK-positive progenitors
formed “secondary” neurospheres when dissociated and re-
plated (Fig. 5 C, g), indicating self-renewal capacity. Control
cultures transfected with cytomegalovirus promoter (PCMV)-
EGFP yielded equivalent percentages of neurospheres in
EGFP-positive and -negative fractions (Fig. S2, available at
http://www.jcb.org/cgi/content/full/jcb.200412115/DC1), indi-
cating that the present findings are not simply due to a general
preference for transfection of sphere-forming cells.
To more accurately determine the frequency of neuro-
sphere-initiating cells (NS-ICs), sorted progenitors from E15
telencephalon cultures were serially diluted. At each density,
MELK-positive progenitors gave rise to significantly greater
numbers of spheres than did LeX-positive progenitors. Approx-
imately 1 out of 10 MELK-positive progenitors were NS-IC,
whereas 1 out of 29 LeX-positive cells was NS-IC (Fig. 5 C, h
and i). Thus, even at an extremely low seeding density, MELK-
expressing cells were highly enriched for NS-IC.
Staining of undifferentiated MELKP-EGFP–derived neu-
rospheres revealed that virtually all cells expressed nestin and
Figure 3. MELK expression in proliferating CNS progenitors in vivo.
The photomicrographs in A–D are of dipped sections sampled from the
regions identified in the brain section at the top. Sections were hybridized
with MELK cRNA, and then stained by immunohistochemistry. (A) Coronal
section through the rostral forebrain at P7. MELK mRNA was restricted to
the germinal epithelium (a and b). Co-expression in brain GZs with PCNA
(a–d, arrows in e). MELK was not detected in extracranial PCNA-positive
cells (f). (B) Limited to no coexpression with GFAP on P1 or P7 (a and b,
arrows), with greater coexpression in adult SVZ (c, arrow). (C) Co-expression
with GFAP in the hippocampus hilar border on P7 (a, arrow). There is no
coexpression with TuJ1 in the dentate gyrus (b, arrow). (D) Granule cell
layer expression in the P7 cerebellum (a and b). MELK mRNA was present
in the outer proliferative region, but not in the inner premigratory TuJ1-pos-
itive granule cells (c). Cells indicated by arrows are shown in the insets.
GCL, granule cell layer; iGCL, inner layer of GCL; oGCL, outer layer of
GCL; V, ventricle. Bar in A: 610 m in a and b; 61 m in c and d; 22 m
in e and f. bar in B: 55 m in a; 45 m in b; 31 m in c. Bar in C: 22 m.
Bar in D: 50 m in a and b; 22 m in c.
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LeX (Fig. 5 D, a and b). After differentiation of primary or
secondary spheres, staining revealed that the spheres formed
neurons, astrocytes, and oligodendrocytes (Fig. 5 D, c–e).
These data demonstrate that MELKP-derived cells are indeed
multipotent, self-renewing progenitors.
 
MELK is expressed by self-renewing 
multipotent progenitors in vivo
 
To examine whether MELK can be expressed by MNP in vivo,
we constructed transgenic reporter mice using the MELK pro-
moter to drive EGFP expression. In general, EGFP expression re-
capitulated the expression pattern of endogenous MELK mRNA
being largely restricted to developing GZ, including the GZ sur-
rounding the lateral ventricles and the rostral migratory stream,
the inner granule zone of the early postnatal hippocampus, and
external granule cells of the neonatal cerebellum (Fig. 6 A, b–e).
Cortical progenitors from P1 transgenic mice were cultured
as neurospheres according to the schemes shown in Fig. 6 A (a).
Primary neurospheres were all EGFP positive (Fig. 6 A, f). After
up to 12 clonal passages over 4 mo, neurospheres remained EGFP
positive (Fig. 6 A, g and h). EGFP-positive neurospheres derived
from the MELK-EGFP transgenic mice were multipotent, con-
taining neurons, astrocytes, and oligodendrocytes after induction
of differentiation at each passage (Fig. 6 A, f). These findings
indicate that MELK expression persists in progenitors within
clonally passaged neurospheres throughout multiple rounds of
self-renewal. To determine whether sphere-initiating progenitors
are EGFP positive, we performed FACS for EGFP and then grew
neurospheres at high and clonal densities from P1 forebrain. As is
shown in Fig. 6 B (b), EGFP-expressing cells yielded neuro-
spheres both in clonal and high density conditions. In contrast,
MELK-negative progenitors failed to form neurospheres even in
high density conditions. Thus, neurosphere-forming cells derived
from the developing brain express MELK, and MELK expression
persists throughout multiple passages, suggesting that it is ex-
pressed by long-term, self-renewing progenitors.
 
MELK regulates MNP proliferation
 
The studies thus far demonstrate that MELK is expressed by
MNPs. To determine the function of MELK in these cells, we
assessed the effects of overexpression and knockdown accord-
ing to the scheme shown in Fig. 7 A. Neurospheres were gener-
ated from the following: E12 telencephalon as a stage of neuro-
genesis, E15 and P0 cerebral cortex as stages of transition and
gliogenesis, respectively. Adherent cultures of progenitors de-
rived from neurospheres were transduced with expression vec-
tors or appropriate double-strand RNA designed to be small
inhibitory RNA (siRNA) or controls. Using PCMV-EGFP we
estimated transfection efficiency at 
 

 
70% (unpublished data).
Specificity and efficacy of the overexpression and siRNA vec-
tors used is described in the online supplemental data, and illus-
trated in Fig. S3 (available at http://www.jcb.org/cgi/content/
full/jcb.200412115/DC1). In addition to mock transfection, we
used NCS and CRT1 siRNAs as positive and negative controls,
due to previous studies demonstrating that NCS promotes MNP
proliferation, whereas CRT1 does not (Rauch et al., 2000; Tsai
and McKay, 2002). These adherent cultures varied in their char-
Figure 4. The MELK promoter is active only in undifferentiated neural
progenitors. (A) FACS analysis of UD cells transfected with the MELK pro-
moter–containing (a) and control (b) EGFP clones. (c) RT-PCR for MELK
after separation of the fluorescence-positive (P3) and -negative (P1) cells in
panel a by flow cytometry. (B) Colocalization of EGFP fluorescence driven
by the MELK promoter (a–p) or the CMV promoter (t) in undifferentiated
progenitors or in differentiated progenitors (q–s, u, and v) with nestin,
NG2, RC2, BLBP, Sox2, GFAP, O4, or TuJ1 immunoreactivity. Bar in B:
44 m in all except for s, where it equals 22 m.
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acteristics, depending on age. E12 telencephalic cells largely
contained nestin/LeX-positive cells, with few cells bearing dif-
ferentiation markers, whereas cultures from older animals con-
tained more cells expressing differentiation markers (Fig. 7 B,
a–g). Spheres were generated from transfected cultures and
propagated. To assay sphere potency, we differentiated E12-
derived spheres by removal of growth factor and plating on sub-
strate, and found that they reliably and readily formed neurons,
astrocytes, and oligodendrocytes (Fig. 7 B, h–j).
Overexpression of MELK in neural progenitors yielded in-
creased numbers of spheres after transfection. MELK knock-
down resulted in the opposite effect: a diminished number of
spheres compared with controls, indicating that MELK regulates
the proliferation of sphere-forming progenitors (Fig. 7 C, a–c).
As expected, knockdown of NCS had effects similar to that of
MELK siRNA, whereas knockdown of CRT1 had no effect. The
total number of cells within cultures was affected as well, with
MELK overexpression resulting in a greater number of cells and
knockdown in fewer cells. MELK overexpression resulted in
significantly larger spheres, compared with control conditions or
siRNA for MELK (Fig. 7 C, e). This latter finding suggests that
MELK overexpression influences not only sphere-initiating
cells, but also cells that contribute to overall sphere size.
MELK knockdown inhibited (whereas overexpression
enhanced) BrdU labeling indices after pulse labeling, indicat-
ing a direct effect on proliferation (Fig. 7 C, f). The number of
dead or dying cells was not affected by siRNA treatment (Fig.
7 C, g). These data suggest that MELK influenced proliferation
itself rather than survival of proliferating cells.
Spheres generated after MELK knockdown or overex-
pression were multipotent, yielding neurons, astrocytes (Fig.
7 D), and oligodendrocytes (not depicted). The neurogenic
capacity was not significantly altered by the change of
MELK expression, indicating that endogenous MELK likely
regulated the proliferation of sphere-forming cells, which
were, in turn, multipotent, without influencing the relative
numbers of differentiated cells (i.e., the proliferation of com-
mitted progenitors). To determine whether MELK directly
 
cells. (a) Staining of sorted cells (P3 fraction in b) with anti-LeX antibody.
(b) FACS analysis showing LeX-positive (P3) and -negative (P2) fractions.
(c) Percentage of total RT-PCR product in Lex-positive (gray bar) vs. LeX-nega-
tive (white bar) fraction for each gene listed. 100% is the total amount of
GAPDH-normalized signal in LeX-positive and LeX-negative fractions com-
bined. (C) Neurospheres production after LeX sorting or sorting for GFP after
transfection of PMELK-EGFP (a–d). (e) Neurosphere numbers obtained from
sorted cells expressed as a percentage of cells obtained in unsorted popula-
tions. (f) Cell numbers corresponding to the conditions in panel e. (g) Sec-
ondary neurosphere numbers after dissociation of the primary spheres
counted in panel e as a percentage of the primary neurosphere numbers
derived from unsorted progenitors. The graph in panel h demonstrates the
numbers of neurospheres resulting from the seeding of 30, 100, or 300
cells, achieved by serial dilution, of MELK-positive cells and LeX-positive
cells. (i) Frequency of neurosphere-initiating cells (NS-IC). (D) Secondary neu-
rospheres from MELK-positive progenitors were stained as spheres (top pan-
els) or after differentiation in the absence of mitogen. Undifferentiated
spheres intensely labeled with anti-nestin and anti-LeX antibodies (a and b).
Differentiated spheres demonstrate TuJ1-positive neurons, GFAP-positive as-
trocytes, and O4-positive oligodendrocytes (c–e). Asterisk denotes different
from controls, P 
 

 
 0.05; **, P 
 

 
 0.001, ANOVA followed by post-hoc 
 
t
 
 test.
Bar in C: 200 
 

 
m. Bar in D: 110 
 

 
m in a and b; 207 
 

 
m in c–e.
Figure 5.
 
MELK-expressing progenitors are neurosphere-initiating MNPs.
 
(A)
 
 
 
PMELK-EGFP expression overlaps with LeX immunofluorescence. Arrows/
arrowheads indicate LeX-positive, MELK-negative cells in the same culture.
Arrowhead is negative, arrow is positive. (B) MELK expression in LeX-sorted
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influences differentiation, we analyzed the effects of MELK
knockdown and overexpression in adherent E12 cortical pro-
genitors that were then differentiated on the coverslip for 5 d
by withdrawal of bFGF, and found no effect on the formation
of neurons, astrocytes (Fig. 7 D, c and d), or oligodendro-
cytes (not depicted). Together, these functional experiments
indicate that MELK regulates MNP proliferation and their ca-
pacity to self-renew, at least in the short term, without a ma-
jor effect on the proliferation of committed progenitors or on
cell fate decisions.
 
MELK is necessary for the production of 
GFAP-negative MNPs from neonatal 
astrocyte cultures
 
Recent studies have documented the ability of GFAP-positive
cells of the adult forebrain SVZ to form rapidly amplifying
progenitors in the presence of bFGF (Imura et al., 2003; Mor-
shead et al., 2003). These transition processes can be moni-
tored by RT-PCR and immunocytochemistry (Fig. 8, A and
B). 24 h of bFGF treatment resulted in diminished GFAP
mRNA expression and increased NCS expression. MASH1
mRNA was up-regulated after 7 d, but not 24 h of treatment
(Fig. 8 A). On d 0, virtually all the cells in culture were GFAP
immunoreactive, whereas a minority (
 

 
5%) was strongly
LeX positive (Fig. 8, B and C). 5 d after placement in bFGF,
GFAP immunoreactivity had dramatically declined, and
 

 
30% of the total cell numbers were strongly LeX positive
(Fig. 8 B and Fig. 8 C, b). Most of these LeX-positive cells
were either GFAP negative or weakly GFAP positive. These
LeX-positive cells function as progenitors, as the number of
neurospheres produced from the LeX-positive fraction, after 2 d
of bFGF treatment, was markedly higher than the number
Figure 6. MELK-positive cells are self-
renewing multipotent progenitors in vivo. (A, a)
Experimental design of long-term passage of
neurospheres from transgenic reporter mice.
Expression of EGFP in a P8 transgenic mouse
demonstrating specific signals in the SVZ (b
and c), dentate gyrus (DG) of hippocampus
(d), and granule cell layer in cerebellum (e),
all indicated by arrows. (f–m) Neurospheres
grown from P1 cortices were substantially all
EGFP-positive from passage 1 (P1, f) to pas-
sage 12 (P12, h). Inset in (f) shows a wild-type
neurosphere. Differentiated primary spheres
contain TuJ1-positive neurons (i), GFAP-posi-
tive astrocytes (j), and O4-positive oligoden-
drocytes (k). Inset in (i) shows a magnified
positive cell. Differentiated cells from P2 and
P12 neurospheres are shown by immuno-
cytochemistry (l and m). (B, a) Experimental
design of direct FACS from P1 cortex. (b)
Graph shows the number of neurospheres
from PMELK-EGFP() and PMELK-EGFP()
cells both in clonal and nonclonal conditions.
**, P  0.001, ANOVA followed by post-hoc
t test. Undifferentiated clonal neurospheres (c)
were differentiated and stained with TuJ1 (d),
GFAP (e), and O4 (f). Inset in (d) shows a
magnified positive cell. Bar in A: 375 m in b
and c; 188 m in d and e; 44 m in f–j and l;
88 m in k and m. Bar in B:110 m in c; 44
m in d–f.
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from the LeX-negative fraction (Fig. 8 C, a), and the LeX-
positive cell-derived spheres were competent to produce neu-
rons in addition to glia (unpublished data). Together, these
findings are consistent with the hypothesis that the addition of
bFGF to these cultures results in the production of highly pro-
liferative, GFAP-negative, LeX-positive MNPs from GFAP-
positive cells.
After bFGF treatment MELK mRNA expression was
up-regulated, whereas GFAP expression declined (Fig. 8 A).
These observations suggest that high levels of MELK expres-
sion is either a reflection of the MNP state or that MELK reg-
ulates the production of, or transition to, GFAP-negative/
LeX-positive cells. To determine whether this transition was
dependent on MELK, we decreased MELK expression during
Figure 7. MELK regulates neural progenitor proliferation. (A) Experimental design. (B) Characterization of adherent progenitors from neurospheres
generated from E12 telencephalon and P0 cerebral cortices (a–f). Monolayer progenitor cultures from neurospheres were immunostained for nestin, LeX,
GFAP, TuJ1, and O4 antibodies. Propidium iodide (PI) was used for nuclear staining. (g) Relative percentages of adherent cells expressing markers.
(h) LeX staining of undifferentiated secondary spheres. (i and j) LeX, TuJ1, O4, and PI staining of differentiating secondary spheres (C) Sphere counts (a–c),
total cell counts (d), sphere diameters (e), percent BrdU incorporation (f), and percent apoptotic cells (g) after overexpression or knockdown of MELK in ad-
herent progenitors cultured at the ages shown. Controls cultures were transfected with EGFP-expressing cDNA or nucleostemin (NCS) or calreticulin (CRT1)
siRNAs. All graphs are the means  SD. (D) TuJ1 immunoreactivity of differentiating secondary neurospheres, which were derived from primary neuro-
spheres after transfection (a and b) and of adherent progenitors from primary E12 neurospheres that were directly differentiated (c and d) after transfection.
Asterisk denotes different from controls, P  0.05; **, P  0.001, ANOVA followed by post-hoc t test. Bar in B: 110 m in a–f; 215 m in h–j. Bar in D:
235 m in all panels.
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bFGF stimulation. Strikingly, siRNA for MELK, but not for
NCS, resulted in diminished numbers of neurospheres (Fig. 8
C, e) and prevented the increase in numbers of LeX-positive
cells (Fig. 8 B and Fig. 8 C, c). Instead, there was a relative
persistence of GFAP-positive cells (Fig. 8 C, d). Knockdown
of MELK also resulted in the reduced expression of nestin and
SOX2 during bFGF treatment (Fig. 8 D). However, knock-
down did not influence cell survival (Fig. 8 C, f). These data
show that MELK is necessary for the production of GFAP low
or negative, LeX-positive MNPs from progenitors that highly
express GFAP.
 
MELK expression is cell cycle-regulated 
and MELK function is likely mediated 
through the B-myb proto-oncogene
 
Our data thus far indicate that MELK plays an important role in
neural progenitor proliferation. This was somewhat surprising
because other members of the snf1/AMPK family appear to
Figure 8. MELK is necessary for the transition from GFAP-positive into GFAP-negative highly proliferative progenitors in vitro. (A) RT-PCR of cortical
astrocyte cultures after addition of bFGF on d 1 and 7. (B and C) Effects of MELK siRNA on the formation of multipotent progenitors from astrocyte cultures.
(B) Immunostaining for GFAP and LeX after bFGF addition. (C, a) Sphere-forming frequency of LeX-positive and -negative cells derived from GFAP-positive
astrocyte cultures (mean  SD). Change in total cell number (b), LeX-positive cell number (c), GFAP-positive cell number (d), neurosphere numbers (e), and
apoptosis (f) after MELK siRNA or control treatment in bFGF-treated astrocyte cultures. Counts were based on two independent experiments for each con-
dition (ctrl, control; crt1, calreticulin1 siRNA; NCS  nucleostemin siRNA). (D) RT-PCR analysis of cultures, after MELK siRNA or control treatment.
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function in cell survival (Kato et al., 2002; Inoki et al., 2003;
Suzuki et al., 2003a,b). To further explore potential roles that
MELK may play in cellular function, we used a large microar-
ray dataset derived from human brain tumors to identify genes
whose expressions were coregulated with MELK. MELK ex-
pression was highly and significantly correlated with genes
known to play roles in the cell cycle, especially those associ-
ated with the mitosis (M) phase. (Fig. 9 A, a). Genes whose ex-
pression was not correlated with MELK functioned in other
processes as determined by Gene Ontology, including metabo-
lism, transcription, and protein modification. Thus, this genome-
wide analysis of coregulation supports a role for MELK in cell
cycle regulation.
Many genes that play roles in the cell cycle show phase-
dependent transcriptional regulation. Therefore, we sorted
progenitors based on their DNA content and evaluated the ex-
pression of MELK and other progenitor genes. MELK, like
nestin, Sox2, and bmi-1, but unlike Msi1, was most highly
Figure 9. Cell cycle regulation and the B-myb proto-oncogene in MELK function. (A, a) Functional grouping of genes most and least correlated with MELK
expression; P  0.001. (b) RT-PCR after separation of P0 progenitors into apoptotic (A), G0/G1 phases (R), and S/G2/M phases (D). Top panel shows
FACS of P0 neurospheres using PI-stained cells. (c) Cell cycle analysis after separation based on either MELK (using PMELK-EGFP) or LeX expression. (B, a)
Top: RT-PCR of P0 neurospheres (NS) and differentiated neurospheres (DC). Bottom: RT-PCR after LeX sorting of progenitors derived from E12 telencephalon.
(b) B-myb and MELK in situ hybridization. Arrow in adult section indicates expression in the adult hippocampus. (c) RT-PCR after either overexpression or
siRNA knockdown of MELK using telencephalic progenitors derived from E11 animals. Triangle indicates increase in PCR cycle number. (d) Effect of B-myb
knockdown on neurosphere generation. For E11 progenitors, siRNA concentrations were 25 and 100 nM (triangles). For the P0 progenitors, 100 nM was
used. Graph shows the ratio of neurosphere formation for each condition compared with the control condition (mock-transfected on the left, calreticulin
siRNA on the right). Asterisk  different from controls, P  0.05; **, P  0.001, ANOVA followed by post-hoc t test. Abbreviations: ncs, nucleostemin;
msi1, musashi1. Bar in B: 4.5 mm.
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expressed during phases of the cell cycle with 4n DNA content
(S, G2, and M) rather than at G0–G1, indicating that MELK
expression varies with the cell cycle (Fig. 9 A, b). To examine
the cell cycle characteristics of MELK-expressing cells, we
transfected progenitor cultures with the PMELK-EGFP or con-
trol construct and analyzed cell cycle parameters by FACS
(Fig. 9 A, c). Greater numbers of MELK-expressing cells were
found to be in the S and G2/M phases, whereas fewer were in
the G0/G1 phase compared with the total or putative non-
MELK–expressing cells. On the other hand, LeX-positive cells
were not different from the total cell fraction or LeX-negative
cells in their cell cycle parameters.
The data described in this section and those above indi-
cate that MELK functions in the regulation of the cell cycle in
MNPs. However, its mechanism is unknown. Previous studies
have demonstrated the importance of the PTEN/AKT/MTOR
pathway in MNP proliferation (Groszer et al., 2001; Sinor and
Lillien, 2004). However, as described in Fig. S4 (available at
http://www.jcb.org/cgi/content/full/jcb.200412115/DC1), we
did not find evidence that MELK interacts with this pathway.
Recent studies have implicated the protein ZPR9 in the func-
tion of MELK and, in turn, ZPR9 in the function of the cell cy-
cle regulatory proto-oncogene B-myb (Seong et al., 2002,
2003). To determine whether MELK function could be medi-
ated by B-myb in MNP, we first examined Zpr9 and B-myb ex-
pression in cultured neural progenitors (Fig. 9 B, a). As is the
case for MELK, ZPR9 and B-myb were highly enriched in NS
from P0 cortex compared with DC (Fig. 9 B, a, top). Also, like
MELK, B-myb was enriched in the LeX-positive fraction of
neurospheres (Fig. 9 B, a, bottom). B-myb, like MELK, was
also expressed during phases of the cell cycle with 4n DNA
content (Fig. 9 A, b). The brain expression pattern of B-myb
was similar to that of MELK throughout development, with the
exception of the adult hippocampus, where B-myb mRNA was
found to be expressed (Fig. 9 B, b).
MELK siRNA treatment resulted in a down-regulation of
both B-myb and ZPR9, without significantly influencing other
stem cell–related genes such as nestin or SOX2 (Fig. 9 B, c)
48 h after transfection. Knockdown of B-myb produced similar
effects to MELK, resulting in a dose-dependent decrease in
neurosphere formation from progenitors (Fig. 9 C, d). Thus,
these data suggest that inhibition of endogenous MELK ex-
pression down-regulates B-myb, which, in turn, results in the
reduction of neurosphere numbers and is consistent with the
hypothesis that MELK exerts some or all of its actions via reg-
ulation of B-myb expression.
 
Discussion
 
MELK is a member of the SNF1/AMPK family of serine threo-
nine kinases and its function was previously unknown. Here,
we demonstrate that MELK is expressed by and is a marker for
self-renewing, tripotent progenitors, MNP, based on in vivo
and in vitro studies. Functional studies demonstrate that MELK
is critical for MNP proliferation, and that MELK is required for
the transition from GFAP-positive progenitors to rapidly pro-
liferative multipotent GFAP-negative progenitors.
 
MELK in vivo
 
Our in vitro studies take advantage of the quantitative aspects
of neurosphere cultures, a system that allows for the repro-
ducible determination of the numbers of MNP after experi-
mental manipulations. These culture systems, despite their
potential shortfalls, can provide significant insight into the
function of genes in vivo (Groszer et al., 2001; Molofsky et
al., 2003). However, in vitro studies cannot, in isolation,
be used as sole evidence of in vivo function, as the in vivo
environment places specific constraints on progenitor cells.
Therefore, we sought to determine the relevance of our in
vitro findings by detailed examination of MELK expression
in vivo. MELK expression is limited to areas containing pro-
liferating neural progenitors, the periventricular GZ, the de-
veloping hippocampus, and the EGL of the cerebellum. Fur-
thermore, double-labeling studies demonstrate that MELK is
expressed by proliferative cells in these areas. Within the em-
bryonic telencephalon, MELK is clearly expressed by self-
renewing MNP, as MELK is found throughout the prolifera-
tive zones as early as E9, a stage when most of (if not all) the
cells are likely to be MNP rather than committed progenitors
(Cai et al., 2002). It remains to be seen, however, if the MELK
expressed within later GZ is restricted to MNPs or is also ex-
pressed by committed progenitors. The expression of MELK
in granule cell progenitors suggests that MELK can be ex-
pressed by populations of self-renewing, committed progeni-
tors, rather than only MNP.
In the hippocampus, MELK expression was not detect-
able in the adult dentate gyrus, a site of neurogenesis and pre-
sumed location of stem cells (for review see Gage et al., 1998).
Thus, MELK expression is neither present in all neural stem
cells nor required for the multipotent state. The lack of expres-
sion in adult hippocampus does suggest, however, that there
are differences between progenitor cells within the hippocam-
pus and the SVZ. One potential explanation is that MELK is
expressed in a class of highly proliferative progenitors that are
not found in the adult hippocampus. Previous studies have indi-
cated that different types of transitory progenitors are derived
from GFAP-positive stem cells in the adult hippocampus and
the SVZ (Seri et al., 2001). Additionally, studies have shown
differences in neurosphere-forming capacity between cells de-
rived from the dentate gyrus and those derived from the lateral
ventricles, again suggesting fundamental differences between
progenitors derived from the two regions (Seaberg and van der
Kooy, 2002).
 
MELK is a marker for self-renewing 
multipotent neural progenitors in the 
developing forebrain
 
Here, we demonstrate that MELK expression can be used
to prospectively isolate MNP from developing brain. The
MELK promoter element drives EGFP expression faithfully,
allowing for isolation of MELK-expressing cells by FACS.
This approach has been taken using other genes, including
nestin, Msi1, and SOX2 (Roy et al., 2000; Keyoung et al.,
2001). Using the nestin promoter/enhancer or the Msi1 pro-
moter, others have found that 
 

 
1–2% of the isolated, EGFP-
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expressing cells form neurospheres (Keyoung et al., 2001).
Other non-gene based methods have also been used to enrich
for neural stem cells from brain or neurospheres, including
size (Murayama et al., 2002) and exclusion of Hoechst dye
(Kim and Morshead, 2003; side population), the latter of
which yields an approximate 1 in 10 neurosphere formation.
Positive sorting using anti-LeX antibody also enriches for
neural stem cells in adult brain (Capela and Temple, 2002). In
the present study, the relative enrichment for neurosphere ini-
tiation with PMELK-EGFP was greater than that for LeX, as
well as for previously reported results using other promoters
(Roy et al., 2000; Keyoung et al., 2001). There was approxi-
mately the same level of enrichment reported using side popu-
lation purification. The cell-sorting and immunocytochemical
data presented here are consistent with the hypothesis that
MELK-expressing cells are the subset of LeX-positive cells
that form neurospheres.
Our studies with MELK-EGFP transgenic mice indicate
that MELK-expressing cells in the developing forebrain in vivo
can serve as self-renewing multipotent progenitors. MELK-
expressing cells could be cultured as neurospheres that could
be multiply passaged to form new neurospheres at clonal densi-
ties. These neurospheres could then be differentiated with the
resulting production of neurons, astrocytes, and oligodendro-
cytes. Thus, MELK-expressing cells isolated from the brain
contain a population with the characteristics of neural stem
cells—persistent self-renewal and multipotency.
MELK is necessary for MNP proliferation 
in vitro
Here, we demonstrate that MELK is necessary for MNP prolif-
eration from embryonic and early postnatal cortex, a novel
function for this putative kinase. Previous studies of other fam-
ily members in transformed cells have revealed that they
largely mediate cell survival under hostile conditions (Kato et
al., 2002; Inoki et al., 2003; Suzuki et al., 2003a,b). MELK ap-
pears to be unique amongst this family in its capacity to regu-
late the cell cycle.
In vitro, we see diminished numbers of secondary multi-
potent neurospheres in MELK siRNA-treated cultures, indicat-
ing that MELK is necessary for the self-renewal of MNP, at
least in the short term. Part of the definition of stem cells lies in
their capacity to self-renew. It is self-renewing divisions that
allow for the maintenance of a stem cell pool and is critical to
the formation and maintenance of the CNS. During early devel-
opment, the neural tube consists primarily of MNP undergoing
extensive, symmetrical self-renewal. Factors, such as PTEN
(Groszer et al., 2001), Bmi-1 (Molofsky et al., 2003), or the
Wnt pathways (Chenn and Walsh, 2002) that regulate this pro-
cess influence ultimate brain size. The methods used here do
not allow us to determine whether MELK is required for the
long-term self-renewal of neural stem or progenitor cells as op-
posed to just being active in short-term amplifying progenitors.
However, the results from the MELK-EGFP transgenic mice
indicate that MELK is expressed by long-term self-renewing
progenitors, consistent with the hypothesis that MELK is a
self-renewal regulating protein.
MELK regulates the transition of GFAP-
positive cells to a GFAP-negative, 
multipotent state
During the course of late embryonic and postnatal develop-
ment, a population of GFAP-expressing progenitors arises in
the forebrain GZs. These cells, which in the adult brain are
thought to be slowly cycling, give rise to rapidly proliferative
MNPs, which then are capable of generating neuronal-restricted
precursors (Doetsch, 2003). Little is known about the mecha-
nisms underlying how this progression takes place. However,
because MELK mRNA was expressed by some GFAP-contain-
ing cells in the GZs and also regulates the proliferation of rap-
idly cycling progenitors, we hypothesized that MELK would
play a role in this process.
Previous studies demonstrate that GFAP-expressing cells
cultured from the neocortex—presumably the SVZ—form
clonal neurospheres and produce neurons in the presence of
bFGF (Laywell et al., 2000; Imura et al., 2003). Our data sup-
port the hypothesis that a subset of GFAP-positive cells express
LeX and that the addition of bFGF results in the expansion of
this subpopulation, which are then, in turn, multipotent, and
that MELK is required for this process in vitro. It remains to be
seen whether the same function is served in vivo.
Potential mechanisms of MELK function
A previous study of the human MELK orthologue pEg3 sug-
gested that it induces phosphorylation of the cell cycle–related
gene CDC25B, resulting in cell cycle arrest using ectopic ex-
pression in an osteosarcoma cell line (Davezac et al., 2002).
However, our data, taken in sum, strongly indicate that MELK
positively regulates the cell cycle in neural tissue. First, our
functional studies demonstrated that MELK influences prolif-
eration on cultured neural progenitors without dramatically af-
fecting cell survival. We also found that in glioblastoma,
MELK expression was highly correlated with cell cycle–pro-
moting genes. In neural progenitor cultures, MELK expression,
like many cell cycle regulatory genes, varied with phases of the
cell cycle—with higher expression at S/G2/M phase than at
G0/G1. Furthermore, MELK-expressing cells had different cell
cycle characteristics than nonexpressing cells, a result sugges-
tive of more rapid proliferation. Together, these data strongly
support a role for MELK in the promotion of the cell cycle of
rapidly proliferative progenitors. This role is unique to MELK
amongst the snf1/AMPK family members.
Our expression and functional data suggest that MELK
function is mediated by the proto-oncogene, B-myb. This tran-
scription factor is known to promote G1–S transition in cell
lines, and the Drosophila homologue myb regulates the G2–M
transition (Lyon et al., 1994; Oh and Reddy, 1999; Tanaka et
al., 1999). B-myb regulates the proliferation of ES cells (Iwai
et al., 2001) and is required for the formation of the inner cell
mass (Tanaka et al., 1999). Like MELK, B-myb is expressed in
undifferentiated neurospheres, with a decline in expression
during differentiation. We show that MELK knockdown down-
regulates B-myb expression in primary progenitors, and that
B-myb knockdown also inhibits NSC proliferation. Furthermore,
in vivo expression analysis also lends support to the proposed
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mechanism of MELK action—through regulation of B-myb
expression. There is a striking degree of overlap of MELK and
B-myb mRNA expression in vivo, with all areas that express
MELK mRNA also expressing B-myb mRNA.
A potential target of MELK phosphorylation and activa-
tion of B-myb is ZPR9. We also have demonstrated that ZPR9 is
expressed in neurospheres and not in differentiated cells, and its
expression is regulated by MELK expression. Although previous
studies have suggested a direct interaction between MELK and
ZPR9 as well as between ZPR9 and B-myb, our data also sug-
gest that these factors are transcriptionally regulated by MELK.
Further study will be needed to determine the precise relation-
ship between MELK, ZPR9, and B-myb, a potential novel sig-
naling cascade in neural progenitor proliferation.
Conclusions
In summary, MELK is a gene highly expressed in the prolifer-
ating progenitors in vivo and regulates MNP proliferation in
vitro. These findings are important for the study of normal
brain development, for CNS repair, and for pathological states
such as brain tumors, where aberrant progenitor proliferation is
implicated.
Materials and methods
Neural progenitor cultures
Neurosphere cultures were prepared as described previously (Geschwind
et al., 2001). Cortical telencephalon was removed from E12 CD-1 mice,
and cerebral cortex was isolated from older animals (Charles River Labo-
ratories). In some experiments, cortices from conditional PTEN mutants
were used (Groszer et al., 2001). Cells were dissociated with a fire-pol-
ished glass pipette, and resuspended at 50,000 cells/ml in DME/Ham’s
F12 medium (Invitrogen) supplemented with B27 (GIBCO BRL), 20 ng/ml
bFGF (Peprotech), and penicillin/streptomycin (Gemini Bioproducts) and
heparin (Sigma-Aldrich). Growth factors were added every 3 d. For differ-
entiation, culture medium was replaced into Neurobasal (Invitrogen) sup-
plemented with B27 without bFGF onto poly-L-lysine (PLL)-coated dishes,
and maintained up to 5 d. For secondary sphere formation assay, the pri-
mary spheres were dissociated and plated into 96-well microwell plates in
a 0.2-ml volume of growth media at 40,000 cells/ml, and the resultant
sphere numbers were counted at 7 d. For rapamycin treatment, neural
progenitors were incubated with 1 M rapamycin (Sigma-Aldrich) for 2 d
and stained with phospho-S6 antibody (1:300; Cell Signaling).
To assay the influence of gene knockdown or overexpression, the
neurosphere culture system was modified. Neurospheres were propa-
gated for 1 wk and then dissociated with trypsin (0.05%) followed by trit-
uration with a fire-polished pipette. The cells were then placed in DME/
Ham’s F12 with 2% FBS (GIBCO BRL), and were plated onto polyorni-
thine/fibronectin coated glass coverslips (Sun et al., 2001). After 6 h, the
serum-containing medium was removed and the cells were placed back in
the neurosphere growth medium without heparin and supplemented with
20 ng/ml bFGF. Transfection was then performed as described below. To
assay the sphere-forming potential of the transfected cells, they were lifted
off the plate with trypsin (0.05%), incubated briefly in medium containing
10% FBS to inactivate trypsin, spun, and then placed into neurobasal me-
dia supplemented with B27, bFGF, and heparin (Wachs et al., 2003). To
assay the function of cells expressing EGFP driven by the MELK promoter,
neurospheres at 7 d in vitro (DIV) were plated onto coverslips as above
and transfected. Some cultures were then placed into neurosphere condi-
tions to assay sphere-forming potential, whereas others were propagated
and differentiated on the coated coverslips after transfection. Proliferation
activity was measured by BrdU incorporation for 24 h starting at DIV3, us-
ing the Cell Proliferation ELISA BrdU (colorimetric) kit (Roche), according
to manufacturer’s protocol. Readout was the optical density at 492 nm. To
assay cell death, living cultures were incubated for 10 min with propidium
iodide (PI, 2 uM), washed twice in media, and then fixed and counter-
stained with Hoescht. The number of nuclei that were PI positive were
counted per high power field and considered as an indicator of cell
death. The morphological features of condensed (pyknotic) or fragmented
nuclei were used as confirmatory measures.
GFAP-positive astrocyte-enriched cultures
Primary astrocyte cultures were prepared from P1 mouse cortices as de-
scribed previously (Imura et al., 2003). In brief, as cells became confluent
(12–14 DIV) they were shaken at 200 rpm overnight to remove nonadher-
ent cells and to obtain pure astrocytes, and then were passaged onto PLL-
coated coverslips for RNA collection or FGF stimulation. To determine the
expression and function of MELK during the production of MNPs from
GFAP-positive progenitors, the media were changed to neurosphere
growth medium with bFGF. Cell proliferation and cell death were mea-
sured in the same way as for MNP.
N2A neuroblastoma cells
Mouse N2A cells (American Type Culture Collection) were cultured in
DME/Ham’s F12 with 10% FBS, and were passaged when confluent.
Semiquantitative RT-PCR
Total RNA was isolated from each sample using TRIzol (GIBCO BRL), and 1
g RNA was converted to cDNA by reverse transcriptase following the man-
ufacturer’s protocol (Impron). For semiquantitative RT-PCR, the amount of
cDNA was examined by RT-PCR using primers for glyceraldehyde-3-phos-
phate-dehydrogenase gene (GAPDH) as an internal control from 20 to 45
cycles. After correction for GAPDH signal for each set, the resultant cDNA
was subjected to PCR analysis using gene-specific primers listed in Table S1
(available at http://www.jcb.org/cgi/content/full/jcb.200412115/DC1).
The protocol for the thermal cycler was: denaturation at 94C for 3 min, fol-
lowed by cycles of 94C (30 s), 60C (1 min), and 72C (1 min), with the
reaction terminated by a final 10-min incubation at 72C. Control experi-
ments were done either without reverse transcriptase and/or without tem-
plate cDNA to ensure that the results were not due to amplification of geno-
mic or contaminating DNA. Each reaction was visualized after 2% agarose
gel electrophoresis for 30 min, and expression levels were compared be-
tween the cDNA samples on the same gel.
Quantitative RT-PCR
DNase-treated RNA samples (1 g) were directly reverse transcribed with
ImPromt-II RT (Promega). Real-time PCR was performed using a LightCycler
rapid thermal cycler system (Roche Diagnostics) according to the manufac-
turer’s instructions. A mastermix of the following reaction components was
prepared to the indicated end concentrations: 8.6 l water, 4 l betaine
(1 M), 2.4 l MgCl2 (4 mM), 1 l primer mix (0.5 M), and 2 l LightCy-
cler (Fast Start DNA Master SYBR Green I; Roche Diagnostics). LightCycler
Mastermix (18 l) was filled in the LightCycler glass capillaries and 2 l
cDNA was added as PCR template. A typical experimental run protocol
consisted of an initial denaturation program (95C for 10 min), amplifica-
tion and quantification program repeated 45 times (95C for 15 s, 62C
for 5 s, 72C for 15s, followed by a single fluorescence measurement). Rel-
ative quantification was determined using the LightCycler Relative Quantifi-
cation Software (Roche Diagnostics), which takes the crossing points (CP)
for each target transcript and divides them by the reference GAPDH CP.
In situ hybridization and immunohistochemistry
In situ hybridization with brain sections from multiple ages was performed
as described previously using 35S-labeled riboprobes (Kornblum et al.,
1994). For double labeling using in situ hybridization and immunohis-
tochemistry, we used the method described previously with radiolabeled
riboprobes and immunohistochemistry using DAB as chromagen (Korn-
blum et al., 1999).
Immunocytochemistry
Immunocytochemistry of neurospheres, adherent progenitors, and neo-
natal astrocytes were performed as described previously (Kornblum et
al., 1998; Geschwind et al., 2001) using the following antibodies: nes-
tin (Rat401; 1:200; Developmental Studies Hybridoma Bank), LeX
(CD15; 1:200; Invitrogen), TuJ1 (1:500; Berkeley Antibodies), GFAP
(1:1,000; Dako Cytomation), and O4 (1:50; CHEMICON Interna-
tional). Primary antibodies were visualized with Alexa 568– (red), 488–
(green), and 350 (blue)–conjugated secondary antibodies (Molecular
Probes, Inc.). Hoechst 333342 (blue) and PI (red) were used as a fluo-
rescent nuclear counterstain.
Sphere diameter analysis
Secondary neurospheres from E12.5 telencephalon were plated into cov-
erslips and fixed with 4% PFA. Diameters of 30–120 randomly chosen
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spheres from each condition were measured using the Microcomputer Im-
aging Device Program (MCID). A minimum cutoff of 40 m was used in
defining a neurosphere.
Construction of vectors
pCMV-MELK. The full-length coding region of mouse MELK was amplified
by PCR using mouse embryonic neurospheres as a template, and was sub-
cloned into pGEM-T Easy vector (Promega). After sequence verification,
the MELK fragment was subcloned into pCMV-Tag vector (Stratagene) at
NotI site.
PMELK-EGFP. The putative MELK promoter region was defined us-
ing PromoterScan (http://bimas.dcrt.nih.gov/molbio/proscan/). This pro-
gram indicated that the 2.7 kb upstream of the starting ATG codon had
multiple transcription factor binding sequences. A bacterial artificial chro-
mosome (BAC) clone was obtained from BAC/PAC resources (Children’s
Hospital Oakland Research Institute, Oakland, CA). Using this BAC clone
as a template, 3.5 kb and 0.7 kb upstream of the starting ATG codon of
mouse MELK was amplified and subcloned into T Easy vector. After the se-
quence confirmation, a genomic region of MELK promoter was fused to
EGFP polyA (CLONTECH Laboratories, Inc.), yielding PMELK-EGFP.
siRNA synthesis
siRNA was synthesized using the Silencer siRNA Construction Kit follow-
ing the manufacturer’s instructions (Ambion). Four different targeting se-
quences were designed from coding region of mouse MELK. Each of the
four demonstrated different levels of mRNA knockdown, and one was cho-
sen for further analysis. The sequence is listed in Table S1.
Flow cytometry and sorting
Flow cytometry and sorting of EGFP cells from E12- and E15-derived neu-
ral progenitors was performed with a FACSVantage (Becton Dickinson) us-
ing a purification-mode algorithm. Gating parameters were set by side and
forward scatter to eliminate dead and aggregated cells. Cells transfected
with a promoterless EGFP vector were used as a negative control to set the
background fluorescence; false positive cells were 0.5%. For isolation of
LeX cells (Capela and Temple, 2002), E12 progenitors were labeled
with LeX antibody (Invitrogen) for 30 min and Alexa 530 was used for flow
cytometry and sorting. Background signals were determined by incubation
of the same set of progenitors without primary antibody.
Transient transfection
Cells were transfected using LipofectAMINE 2000 (Invitrogen) following
the manufacturer’s protocol. For transfection of plasmid vectors, the cells
were incubated with reagents for 6 h with the primary progenitor cells,
and for 24 h with N2a cells. For transfection of the double-stranded
siRNA complex, serial dilutions of siRNA from 5 to 200 nM were tested to
obtain specific knockdown of the gene of interest, and 100 nM was cho-
sen as the concentration for functional study. Incubation with siRNA com-
plex was 6 h with primary cells and 24 h with cell lines.
Image acquisition
Photomicrographs were obtained using a microscope (model IX50; Olym-
pus) fitted with a bright- and dark-field condenser using a digital camera
(model C2020; Olympus). Digital images were manipulated using Adobe
Photoshop 7.0.2 in order to accurately reflect direct observation.
Online supplemental materials
Fig. S1 depicts genomic structure of human and mouse MELK and pro-
moter characterization. Fig. S2 shows sphere formation after transfection
with PCMV-EGFP. Fig. S3 shows that MELK expression is specifically al-
tered by the expression vector and by synthesized siRNA. Fig. S4 shows
that MELK function is parallel to the PTEN/Akt pathway. Table S1 lists
primer sequences. Online supplemental material available at http://
www.jcb.org/cgi/content/full/jcb.200412115/DC1.
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